Brochure
GLP-1 Packaging Solutions
Purpose-built container closure solutions for GLP-1 drugs—engineered to protect peptide formulations, support device functionality, and accelerate your path to market.
Status
Published
Format
Brochure
Language
English
Access
Registration Required
Resource Overview
About this Brochure
As demand for GLP-1 receptor agonist drugs continues to expand across diabetes and obesity indications, Datwyler provides a comprehensive and validated portfolio of elastomer components specifically designed to meet the unique challenges of GLP-1 drug packaging. Datwyler's solutions address both robust and sensitive GLP-1 formulations across the two primary delivery formats—3 mL cartridges for pen injectors and 1 mL prefilled syringes for auto-injectors. The portfolio includes NeoFlex™ fluoropolymer-coated plungers, offering excellent peptide compatibility with low extractables and leachables; DuraCoat™ bi-layer combiseals for cartridge closure; and rigid needle shields in FM30 compound. All plungers are produced in Datwyler's FirstLine® facilities and are available in ready-to-use (RTU) and ready-to-process (RTP) formats. With worldwide production capacity, proven device functionality, consistency in rubber compound across both ends of the drug container, and regulatory filing support to ease drug registration, Datwyler is positioned as a strategic partner for manufacturers seeking reliable GLP-1 packaging solutions at global scale.
Access This Resource
Download the Brochure
Continue to access the full resource.
Access the Resource
Quick access in under 30 seconds.
